CASI Pharmaceuticals, Inc. 4
4 · CASI Pharmaceuticals, Inc. · Filed Nov 14, 2014
Insider Transaction Report
Form 4
CAPITELLI SARA B
VP, Finance and PAO
Transactions
- Award
Stock Options (Right to Buy)
2012-08-15+20,000→ 20,000 totalExercise: $1.99Exp: 2022-08-15→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]The stock options vested as a result of the reported license transaction with Spectrum Pharmaceuticals, Inc. on September 17, 2014.